Barkan et al. found that the dormant-to-proliferative switch was dependent on the engagement of integrin β1 (ITGB1) and downstream signalling via activation of FADK 1, Src, ERK, and myosin light-chain kinase (MLCK) in breast cancer D2.0R cells. Here, MYLK is linked to breast carcinoma.